Fig. 1From: Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosisTrends of PaO2/FiO2 ratio of each patient at the time of enrollment (T0), within 24 h after the infusion of the first (T1) and second (T2) dose of BM-MSCs, administrated 15 days apart PaO2 partial pressure (arterial) of oxygen; FiO2 fraction of inspired oxygenBack to article page